NCT04135885

Brief Summary

Research purposes:Comparison of preoperative folic acid and placebo intervention on postoperative recovery of sputum in children undergoing general anesthesia for head and neck and maxillofacial surgery Test type:Randomized, double-blind, placebo-controlled, prospective study Randomized grouping: Patients were randomized into an intervention group (fed for 7 days before surgery) and a placebo group (7 days for placebo) Test subjects: recruitment and sample size calculation, inclusion criteria, exclusion criteria, shedding cases, trial suspension, rejection criteria, trial termination,Test contents Evaluation indicators: main observation indicators, secondary observation indicators Adverse events: definition of adverse events, recording of adverse events, treatment of adverse events, assessment of adverse events, serious adverse events, definition of serious adverse events, recording and reporting of serious adverse events

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 23, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

December 30, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

October 25, 2019

Status Verified

October 1, 2019

Enrollment Period

2 years

First QC Date

October 21, 2019

Last Update Submit

October 23, 2019

Conditions

Keywords

Folic AcidPlacebo

Outcome Measures

Primary Outcomes (1)

  • The incidence of sputum in children

    The incidence of sputum in children with major indicators was tested by chi-square test or exact probability method.

    8 days

Study Arms (2)

Intervention group

EXPERIMENTAL

Intervention group: patients took 7 days of folic acid tablets before surgery (0.3mg/d for children aged 1-3, 0.4mg/d for children aged 4\~5 years, dissolved in 20ml brown sugar water.)

Drug: Folic Acid

Placebo group

EXPERIMENTAL

Placebo group: The patient received the same dose of brown sugar water for 7 days before surgery. Folic acid dose selection is based on the maximum daily intake of children(tolerable upper intake levels,UL)

Drug: Folic AcidDrug: Placebos

Interventions

The patient was continuously taking 7 ml of a brown sugar aqueous solution containing a certain amount of folic acid for 7 days before surgery (0.3 mg/d for children with 1-3 years old and 0.4 mg/d for children aged 4 to 5, once a day). After the operation, the PAED scores were performed every 10 minutes during the recovery of the child, at the time of extubation, and within 30 minutes after extubation. The PAED scores of all the children were performed by the same measurer. (The total score is 0\~20 points, and the score ≥10 points is defined as the recovery period).

Intervention groupPlacebo group

Patients in the placebo group received 20 ml of an aqueous solution of brown sugar with the same concentration as the intervention group on the 7th day before surgery. After the operation, the PAED scores were performed every 10 minutes during the recovery of the child, at the time of extubation, and within 30 minutes after extubation. The PAED scores of all the children were performed by the same measurer. (The total score is 0\~20 points, and the score ≥10 points is defined as the recovery period).

Placebo group

Eligibility Criteria

Age1 Year - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA is graded from I to II
  • Children between the ages of 1 and 5
  • The weight is greater than or equal to 8.5kg
  • It is planned to undergo head and neck and maxillofacial surgery under general anesthesia

You may not qualify if:

  • Children with a history of respiratory infection within 1 week
  • Children with congenital malformations such as congenital heart disease
  • Children with central nervous system diseases or those with mental disorders or mental disorders
  • Children with long-term use of sedative or analgesic drugs
  • Children with severe liver and kidney dysfunction
  • receiving folic acid supplementation therapy or taking related derivatives
  • Taking drugs that affect absorption in the past 1 month, such as sulfonamides, aspirin, etc.
  • Participated in other related clinical studies in the past 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology. 2004 May;100(5):1138-45. doi: 10.1097/00000542-200405000-00015.

    PMID: 15114210BACKGROUND

MeSH Terms

Interventions

Folic Acid

Intervention Hierarchy (Ancestors)

PterinsPteridinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • ren zhou, Doctor

    shanghai Ninth People Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

lei zhang, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2019

First Posted

October 23, 2019

Study Start

December 30, 2019

Primary Completion

December 30, 2021

Study Completion

December 30, 2021

Last Updated

October 25, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share